CYTO Altamira Therapeutics
- 1.4700
- -0.1300-8.13%
Altamira Therapeutics News
Altamira Therapeutics | 20-F/A: Registration statement / Annual report / Transition report (Amendment)
Altamira Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Altamira Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Altamira Therapeutics | 20-F: Registration statement / Annual report / Transition report
Altamira Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Altamira Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Altamira Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Altamira Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Altamira Therapeutics | 6-K/A: Report of foreign private issuer (related to financial reporting)
Altamira Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Altamira Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Altamira Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Altamira Therapeutics | 20-F: FY2022 Annual Report
Altamira Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Altamira Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Altamira Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Altamira Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Altamira Therapeutics | 20-F: FY2021 Annual Report
Altamira Therapeutics | 20-F: FY2020 Annual Report
Altamira Therapeutics | 20-F: FY2019 Annual Report
Analysis
Price Target
No Data
